Xcout Intel
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. is a regenerative medicine company headquartered in Delray Beach, Florida. The clinical-stage firm focuses on developing specialized pharmaceutical treatments and therapies for conditions related to smell loss.
Subscribe to see Cyrano Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cyrano Therapeutics, Inc. at a glance
Cyrano Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $16.1M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $9M in January 2024. Xcout tracks 10 named people at Cyrano Therapeutics, Inc., including Ron Kuppersmith (Chief Clinical Advisor).
Cyrano Therapeutics, Inc. leadership
- Ron KuppersmithChief Clinical Advisor
- Rick GeoffrionFounder, President and CEO & Board Member
- Krista GeoffrionVP of Clinical Affairs
- Joe SmithHead of Business Development
- Michael LustyHead of CMC
- Michaela KennedyController
4 more named people on record for Cyrano Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Cyrano Therapeutics, Inc. funding rounds
At least $16.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $9M | 4 named | |
| — | $3M | 4 named | |
| SEC Form D filing | $4.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cyrano Therapeutics, Inc. competitors
A few of Cyrano Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
CiRC Biosciences is a privately held regenerative medicine and cell therapy company founded in 2019 and based in Chicago, Illinois, focused on developing cellular reprogramming solutions for degenerative diseases.
ChemoSensoryX Biosciences SA is a biotechnology company that provides discovery products and services related to chemical communications mediated by human olfactory and taste receptors. Utilizing a proprietary technology platform and screening facilities, the company develops solutions for odor and taste management, including malodor blockers, pleasant odor enhancers, and applications for flavors, fragrances, and drug discovery.
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
GenrAb, Inc. is a Dallas, Texas-based developer focused on creating first-in-class neuroprotective therapies. The company recently completed significant private financing to accelerate the development of its therapeutic pipeline.
Cynata Therapeutics is a biotechnology research company headquartered in Cremorne, Australia, focused on therapeutic products and stem cell technology.
Rinri Therapeutics is a private biotechnology company headquartered in Sheffield, South Yorkshire, United Kingdom. Founded in 2018, the firm focuses on regenerative medicine research to develop first-in-class therapeutics for treating hearing loss and neurological conditions.
Get Cyrano Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cyrano Therapeutics, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access